Back to Rheumatology



Lupus Market Research

What is Lupus?

Lupus is a chronic autoimmune condition that causes a multitude of symptoms, attacking joints, skin, and internal organs in particular. Lupus strikes mostly women of childbearing age. However, men, children, and teenagers develop lupus, as well. Certain ethnic groups—including African American, Asian, Hispanic/Latino, and Native American—are at higher risk for developing lupus than the rest of the population. While the cause of lupus is unknown, medical experts presume it may manifest due to genetic predisposition, a response to hormones, or triggers such as: ultraviolet (UV) rays, infections, antibiotics, previous injuries, emotional stress, and more. While “lupus” is used as an all-encompassing term, there are various forms of lupus, including systemic lupus erythematosus (SLE), which makes up the bulk of all lupus cases, lupus nephritis (LN), where the immune system attacks the kidneys, and cutaneous lupus erythematosus (CLE), where the immune system affects the skin.  As many as half of the SLE patients may develop LN, which can cause serious and sometimes fatal complications, such as kidney failure, in which a patient may be put on dialysis or need a kidney transplant.

Spherix Global Insights – Rheumatology – Lupus

Spherix Global Insights’ rheumatology therapeutic team is a leading provider of independent syndicated lupus market research, insights, business intelligence & advisory services.

Spherix’s studies publishing this year covering Lupus include:

  • RealTime Dynamix™: Lupus Nephritis (US)
  • RealTime Dynamix™: Systemic Lupus Erythematosus (US)
  • RealTime Dynamix™: Systemic Lupus Erythematosus (EU)
  • Patient Chart Dynamix™: Lupus Nephritis (US)
  • Patient Chart Dynamix™: Systemic Lupus Erythematosus (US)
  • Patient Chart Dynamix™: Systemic Lupus Erythematosus (EU)

Spherix’s RealTime Dynamixservice includes quarterly or semiannual reports, respectively in the US and EU, providing an unbiased view of the competitive landscape within the lupus market.

Spherix’s Patient Chart Dynamixservice includes patient level data detailing clinical and non-clinical patient demographics, along with rationale for treatment choices. It reveals real patient management patterns through rigorous analysis of large-scale patient chart audits.

Follow us for rheumatology industry news, insights & analysis:

For Guests & Current Clients

For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:


Get more information on Lupus Coverage